Pfizer Limited (NSE: PFIZER)

India flag India · Delayed Price · Currency is INR
4,803.85
-28.75 (-0.59%)
Dec 24, 2024, 3:30 PM IST
13.83%
Market Cap 219.77B
Revenue (ttm) 22.38B
Net Income (ttm) 6.18B
Shares Out 45.75M
EPS (ttm) 135.06
PE Ratio 35.57
Forward PE n/a
Dividend 35.00 (0.72%)
Ex-Dividend Date Aug 21, 2024
Volume 21,461
Open 4,807.00
Previous Close 4,832.60
Day's Range 4,774.05 - 4,876.10
52-Week Range 3,950.00 - 6,451.15
Beta 0.25
Analysts n/a
Price Target n/a
Earnings Date Feb 14, 2025

About Pfizer

Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers internal medicine and anti-infectives services to hospitals and nursing homes. It serves healthcare... [Read more]

Sector Healthcare
Founded 1950
Employees 1,721
Stock Exchange National Stock Exchange of India
Ticker Symbol PFIZER
Full Company Profile

Financial Performance

In 2023, Pfizer's revenue was 21.93 billion, a decrease of -9.55% compared to the previous year's 24.25 billion. Earnings were 5.51 billion, a decrease of -11.64%.

Financial Statements

News

There is no news available yet.